NCT04038619 2026-03-18
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
707 trialsNCT06412510 2026-03-18
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Case Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT07209449 2026-03-18
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07480785 2026-03-18
TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
Zhejiang University
Phase NA Recruiting
NCT06969833 2026-03-17
BCB-OVAIRE
Centre Oscar Lambret
Phase NA Recruiting
NCT03785574 2026-03-16
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT05231122 2026-03-16
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT06412120 2026-03-16
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
University of Miami
Phase 4 Recruiting
NCT06483048 2026-03-16
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
Mayo Clinic
Phase 1 Recruiting
NCT07282158 2026-03-13
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Fred Hutchinson Cancer Center
Phase NA Recruiting
NCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
NCT07469709 2026-03-13
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Recruiting
NCT05269381 2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2 Recruiting
NCT05758688 2026-03-12
PROPS GYN
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting
NCT06349642 2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
NCT07050771 2026-03-12
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
The Methodist Hospital Research Institute
Phase 2 Recruiting
NCT03968406 2026-03-11
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05819892 2026-03-11
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05952453 2026-03-11
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
University of Alabama at Birmingham
Phase 2 Recruiting
NCT07461818 2026-03-11
POC
Basic Health International, Inc.
Phase NA Recruiting
NCT04712851 2026-03-10
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT07460180 2026-03-10
PROOV
The Netherlands Cancer Institute
Phase 1/2 Recruiting
NCT06142760 2026-03-09
AIM-C1
University Hospital Heidelberg
Phase NA Recruiting
NCT00900575 2026-03-06
Cervical Cancer Detection Using Optical Spectroscopy
Duke University
Phase NA Recruiting
NCT04107181 2026-03-06
Calla
Duke University
Phase NA Recruiting
NCT05977621 2026-03-06
(TRUS)
Duke University
Recruiting
NCT03853915 2026-03-05
HPVDNA02
University Health Network, Toronto
Phase NA Recruiting
NCT04575935 2026-03-05
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT04723095 2026-03-05
NeCTuR
M.D. Anderson Cancer Center
Recruiting
NCT04857528 2026-03-04
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Recruiting
NCT06083844 2026-03-04
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06268665 2026-03-04
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
University of California, Davis
Phase 2 Recruiting
NCT06321484 2026-03-04
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Dana-Farber Cancer Institute
Phase 1 Recruiting
NCT06746428 2026-03-03
ACTIVATE
Inova Health Care Services
Phase NA Recruiting
NCT06935344 2026-03-03
PROVE
Catholic University of the Sacred Heart
Recruiting
NCT06968871 2026-03-03
Ameliorated Pap Tests and Cervical Cancer Screening Participation
National Taiwan University Hospital
Phase NA Recruiting
NCT07121738 2026-03-03
HEAL-GYN
AdventHealth
Phase NA Recruiting
NCT07447050 2026-03-03
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
Phase 2 Recruiting
NCT06369155 2026-03-02
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT07125209 2026-03-02
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
University of Wisconsin, Madison
Recruiting
NCT07220239 2026-03-02
SCREEN-CUP
Brigham and Women's Hospital
Phase NA Recruiting
NCT07372248 2026-03-02
Thermal Artifact in Patients Undergoing Conization: A Clinical Study
Saglik Bilimleri Universitesi
Phase NA Recruiting
NCT07433660 2026-03-02
THRIVE
WellSpan Health
Recruiting
NCT07443475 2026-03-02
Electrochemotherapy for Recurrent Vulvar Cancer
Institute of Oncology Ljubljana
Phase 2 Recruiting
NCT05574673 2026-02-27
HERO
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Recruiting
NCT05639972 2026-02-27
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
Phase 1/2 Recruiting
NCT06511037 2026-02-27
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Phase EARLY_PHASE1 Recruiting
NCT07033819 2026-02-27
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT07282834 2026-02-27
Charlie-2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 2 Recruiting
NCT07428330 2026-02-27
CASCADE3001A
UNC Lineberger Comprehensive Cancer Center
Phase NA Recruiting